Hopefor everyone dealing with cancer.
在Elekta,我们有一个统一的目的,激励us as a company and as individuals—Hope for everyone dealing with cancer. It drives us towards our VISION – A world where everyone has access to the best cancer care. And we plan to get there through our MISSION – We improve patient lives by working together with our customers and partners.
作为精确放射治疗解决方案的领先创新者，Elekta致力于确保每个患者都可以获得最佳的癌症护理。雷竞技下载二维码
Our offering allows clinicians to treat more patients with increased quality, both with value-creating innovations in solutions and AI-supported service based on a global network.
走向每个人都可以获得最好的癌症护理的世界雷竞技下载二维码
For almost half a century we've been working openly and proactively with clinicians and our partners to develop outcome-driven and cost-efficient solutions that meet evolving patient needs, no matter where they are in the world. To us it's personal and our global team of 4,700 employees combine passion, science and imagination to profoundly change cancer care, improve patient care and bring hope to everyone dealing with cancer.
“Today's shortage in radiotherapy equipment is unacceptable. We have a responsibility to change this and will do our part by delivering new, innovative solutions for cancer care."
Gustaf Salford, President and CEO
我们改善癌症护理的策略雷竞技下载二维码
We want to do our part to move towards a world where everyone has access to the best cancer care. With our strategy ACCESS 2025 we set the focus on closing the access gap, elevating cancer care and increasing the patients' participation in their own care.
What does access to the best cancer care mean to Elekta?
AVAILABILITY of Care
在全球范围内改善物理进入放射疗法。通过在服务不足的市场中发展安装的基础（机器数量），我们希望确保全球人口中有更大的份额可以使用放射治疗。
2025 MILESTONE
+300M people
to gain access to RT via 825 additional Elekta linacs in underserved markets
ELEVATION of Care
Improving patient access to better and more efficient care by driving clinical adoption of new technology, optimal utilization of available technology and improving clinical decision support.
2025 MILESTONE
2倍至4倍
double the clinical usage of short course treatment (hypofractionation) and quadruple the usage of adaptive treatments among Elekta customers
参与护理
Increasing patient involvement in their own care journey and enhancing the care teams' ability to improve clinical outcomes through access to deeper and richer patient-reported insights.
2025 MILESTONE
+20%
Elekta客户的患者正在积极与自己的护理旅程互动（今天<1％）
Experience the difference
Discover how partnering with Elekta gives you access to versatile solutions, a culture of innovation and a true commitment to partnership.
Learn more
- WHO Report on cancer, available athttps://www.who.int/publications/i/item/who-report-on-cancer-setting-priorities-investing-wisely-and-providing-care-for-all(excl. non-melanoma skin cancer).
- Ferlay J, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon: International Agency for Research on Cancer, 2020; UN World Population Prospects 2019; International Atomic Energy Agency: DIRAC (Directory of Radiotherapy Centres), 2021
- Atun et al, Expanding global access to radiotherapy, The Lancet Oncol 2015 Sep; 16(10): 1153-86https://pubmed.ncbi.nlm.nih.gov/26419354/.